International Journal of Clinical Case Reports, 2025, Vol.15, No.4, 171-181 http://medscipublisher.com/index.php/ijccr 181 Webster A., Nagler E., Morton R., and Masson P., 2017, Chronic kidney disease, The Lancet, 389: 1238-1252. https://doi.org/10.1016/S0140-6736(16)32064-5 Yamada S., and Nakano T., 2023, Role of chronic kidney disease (CKD)-mineral and bone disorder (MBD) in the pathogenesis of cardiovascular disease in CKD, Journal of Atherosclerosis and Thrombosis, 30(8): 835-850. https://doi.org/10.5551/jat.RV22006 Yan M., Chao C., and Lin S., 2021, Chronic kidney disease: strategies to retard progression, International Journal of Molecular Sciences, 22(18): 10084. https://doi.org/10.3390/ijms221810084 Yang L., Wang B., Ma L., and Fu P., 2022, Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease, Frontiers in Pharmacology, 13: 971032. https://doi.org/10.3389/fphar.2022.971032 Wang A., 2024, The application and challenges of integrating multiomics data in individualized therapy, International Journal of Molecular Medical Science, 14(1): 90-99. https://doi.org/10.5376/ijmms.2024.14.0012 Zoccali C., Vanholder R., Massy Z., Ortiz A., Sarafidis P., Dekker F., Fliser D., Fouque D., Heine G., Jager K., Kanbay M., Mallamaci F., Parati G., Rossignol P., Więcek A., and London G., 2017, The systemic nature of CKD, Nature Reviews Nephrology, 13(6): 344-358. https://doi.org/10.1038/nrneph.2017.52
RkJQdWJsaXNoZXIy MjQ4ODYzNA==